CCM
FURX

Consonance Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Consonance Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,440
Closed -$1.43M – 32
2014
Q2 		$1.43M Sell
13,440
-603,055
-98% -$59.1M 0.21% 24
2014
Q1 		$53.6M Sell
616,495
-32,334
-5% -$2.5M 7.98% 3
2013
Q4 		$27.3M Sell
648,829
-112,935
-15% -$4.64M 4.47% 7
2013
Q3 		$33.5M Buy
761,764
+111,156
+17% +$4.6M 8.38% 3
2013
Q2 		$22.2M Buy
+650,608
New +$22.8M 7.88% 6

Consonance Capital Management's FURX Position: Q3 2014 in Review

Consonance Capital Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 13,440 shares — an estimated $1.43M sold.

Consonance Capital Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $53.6M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Consonance Capital Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Consonance Capital Management sold 13,440 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $1.43M.
  • Consonance Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Consonance Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $53.6M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Consonance Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.